OGEN
Oragenics Inc.
stockNYSEAMERICAN
oragenics is a publicly-traded biopharmaceutical company with a pipeline of unique proprietary technologies. offerings are based on the probiora3 technology and brands include evoraplus™ is a new, one-of-a-kind probiotic mint that naturally supports gum and tooth health while freshening breath and whitening teeth. oragenics has a number of products in discovery, preclinical and clinical development, with a concentration in the main therapeutic area of infectious diseases, in diagnostics, and in oral health.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 0.40 | 2026-10-26 | -6.15% | -1.328 |
| 1M | 0.48 | 2026-10-01 | -22.08% | -0.380 |
| 3M | 0.50 | 2026-07-31 | -25.20% | 0.913 |
| 6M | 0.62 | 2026-05-01 | -39.68% | 0.372 |
| 1Y | 1.23 | 2025-10-31 | -69.47% | 1.306 |
| 2Y | 8.91 | 2024-11-01 | -95.80% | — |
| 5Y | 1,250.82 | 2021-11-01 | -99.97% | 0.934 |
Oragenics Inc. (NYSEAMERICAN:OGEN) stock price today is $0.37, and today's volume is 9,214. OGEN is down 0.053% today. The 30 day average volume is 23,516. OGEN market cap is $1.69M with 4.51M shares outstanding.